InMode Ltd. Q3 2024 Earnings Overview
InMode Ltd. (NASDAQ: INMD), a leading provider of medical technology for minimally invasive treatments, faced headwinds in the third quarter of 2024, as disclosed in their recent earnings call. The company reported total revenue of $130.2 million, a decrease from previous forecasts, and revised its full-year revenue guidance downward due to a challenging economic environment and reduced sales. Despite these challenges, InMode achieved a gross margin of 82% and an increase in GAAP diluted earnings per share to $0.65. The call also highlighted management changes aimed at aligning operations with market conditions and maintaining employee safety in Israel.
Key Takeaways
- InMode reported Q3 total revenue of $130.2 million, with net sales of $98.3 million after accounting for preorders.
- Gross margins remained strong at 82%, though operating expenses rose to $57.9 million.
- GAAP diluted earnings per share increased to $0.65, up from $0.54 in the same quarter last year.
- The company revised its 2024 revenue guidance to between $410 million and $420 million.
- CEO Moshe Mizrahy discussed management changes and the introduction of new products, IgniteRF and Optimus Max, which primarily attracted new customers.
Company Outlook
- InMode adjusted its 2024 revenue guidance to $410-$420 million, citing decreased sales in minimally invasive treatments and platform sales.
- Management changes were implemented to better align with market needs.
- The company is exploring relocation of some manufacturing from Israel to Europe to mitigate risks.
Bearish Highlights
- U.S. consumables growth declined, with doctors performing 40% fewer treatments due to high costs.
- The ongoing conflict in Israel poses challenges to operations and employee safety.
- Maintaining the increased average selling price (ASP) for new systems may be difficult.
Bullish Highlights
- InMode reported 610 system installations in Q3, a significant increase from the previous quarter.
- Gross margins are expected to be between 80% and 82%, despite increased transportation costs.
- The company has a strong cash position with $684.9 million in cash and equivalents.
Misses
- Q3 revenue fell short of the company's earlier projections.
- The revised full-year revenue guidance is lower than previously estimated.
Q&A Highlights
- The CEO addressed the potential impact of economic factors on leasing and sales.
- Plans for a promotional upgrade program were discussed, targeting Q4 2023 or early 2024.
InMode Ltd. (NASDAQ: INMD) is navigating a period of economic uncertainty and operational challenges, as reflected in the company's third-quarter earnings call. While the company's gross margins have remained robust, external factors such as increased transportation costs and the ongoing conflict in Israel have necessitated a revision of the full-year revenue guidance and operational strategies. Management is taking proactive steps to realign the organization and ensure the safety of its workforce, while also looking to mitigate manufacturing risks by considering a shift of some operations to Europe. Despite the downturn in U.S. consumables growth, InMode has reported a strong increase in system installations and maintains a healthy cash reserve, positioning it to weather the current economic challenges.
InvestingPro Insights
InMode Ltd. (NASDAQ: INMD) continues to navigate challenging market conditions, as reflected in its recent earnings report. Despite the headwinds, InvestingPro data reveals some intriguing aspects of the company's financial health that may interest investors.
- InMode's P/E ratio stands at 10.06, suggesting that the stock may be undervalued relative to its earnings, aligning with the reported strong gross margins of 82%.
- InMode's revenue for the last twelve months as of Q2 2023 was $416.63 million, which provides context for the revised full-year guidance of $410-$420 million mentioned in the earnings call.
- InMode holds more cash than debt on its balance sheet, corroborating the reported strong cash position.
- Management has been aggressively buying back shares, signaling management's confidence in the company's long-term prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Comments (0)